Ferring Pharmaceuticals to buy Martín Varsavsky's biotech firm Gameto for US$1.3825 billion
Argentine-Spanish entrepreneur Martín Varsavsky announced that Swiss pharmaceutical company Ferring Pharmaceuticals will buy Gameto, his fertility-focused biotech firm, for US$1.3825 billion. The deal was announced at the Annual Congress of the American Society for Reproductive Medicine in Baltimore. Gameto, founded in 2020, develops Fertilo, a product that cuts hormonal injections in fertility treatments by about 80% and is in Phase 3 for FDA approval.
In 30 seconds
- Ferring Pharmaceuticals, a Swiss maker of fertility medicines, will buy Gameto for US$1.3825 billion.
- Gameto, founded in 2020, raised US$127 million across several funding rounds.
- Its Fertilo product cuts hormonal injections by about 80% and is halfway through Phase 3 before the FDA.
IASummary generated by artificial intelligence from a story by La Nación. It may contain errors: the original source prevails.




Comments
Be respectful. Comments reported by several people are hidden until a moderator reviews them.
You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.